AVAH Quote, Financials, Valuation and Earnings

CVS Health Corp. has a net margin of 2.26% compared to Aveanna Healthcare Holdings, Inc.'s net margin of 2.77%. Aveanna Healthcare Holdings, Inc.'s return on equity of -- beat CVS Health Corp.'s return on equity of 2.28%.

Aveanna Healthcare Holdings, Inc. has a consensus price target of $11.00, signalling upside risk potential of 48.05%. On the other hand CVS Health Corp. has an analysts' consensus of $96.38 which suggests that it could grow by 18.03%. Given that Aveanna Healthcare Holdings, Inc. has higher upside potential than CVS Health Corp., analysts believe Aveanna Healthcare Holdings, Inc. is more attractive than CVS Health Corp..

Aveanna Healthcare Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CVS Health Corp. has a beta of 0.492, suggesting its less volatile than the S&P 500 by 50.806%.

Aveanna Healthcare Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health Corp. offers a yield of 3.26% to investors and pays a quarterly dividend of $0.67 per share. Aveanna Healthcare Holdings, Inc. pays -- of its earnings as a dividend. CVS Health Corp. pays out 191.23% of its earnings as a dividend.

Aveanna Healthcare Holdings, Inc. quarterly revenues are $621.9M, which are smaller than CVS Health Corp. quarterly revenues of $105.7B. Aveanna Healthcare Holdings, Inc.'s net income of $14.1M is lower than CVS Health Corp.'s net income of $2.9B. Notably, Aveanna Healthcare Holdings, Inc.'s price-to-earnings ratio is 20.64x while CVS Health Corp.'s PE ratio is 59.02x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aveanna Healthcare Holdings, Inc. is 0.68x versus 0.26x for CVS Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Humana, Inc. has a net margin of 2.26% compared to Aveanna Healthcare Holdings, Inc.'s net margin of -2.39%. Aveanna Healthcare Holdings, Inc.'s return on equity of -- beat Humana, Inc.'s return on equity of 6.77%.

Aveanna Healthcare Holdings, Inc. has a consensus price target of $11.00, signalling upside risk potential of 48.05%. On the other hand Humana, Inc. has an analysts' consensus of $223.88 which suggests that it could grow by 19.54%. Given that Aveanna Healthcare Holdings, Inc. has higher upside potential than Humana, Inc., analysts believe Aveanna Healthcare Holdings, Inc. is more attractive than Humana, Inc..

Aveanna Healthcare Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.440, suggesting its less volatile than the S&P 500 by 55.989%.

Aveanna Healthcare Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana, Inc. offers a yield of 1.89% to investors and pays a quarterly dividend of $0.89 per share. Aveanna Healthcare Holdings, Inc. pays -- of its earnings as a dividend. Humana, Inc. pays out 36% of its earnings as a dividend. Humana, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Aveanna Healthcare Holdings, Inc. quarterly revenues are $621.9M, which are smaller than Humana, Inc. quarterly revenues of $32.5B. Aveanna Healthcare Holdings, Inc.'s net income of $14.1M is higher than Humana, Inc.'s net income of -$776M. Notably, Aveanna Healthcare Holdings, Inc.'s price-to-earnings ratio is 20.64x while Humana, Inc.'s PE ratio is 19.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aveanna Healthcare Holdings, Inc. is 0.68x versus 0.17x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Marpai, Inc. has a net margin of 2.26% compared to Aveanna Healthcare Holdings, Inc.'s net margin of -86.55%. Aveanna Healthcare Holdings, Inc.'s return on equity of -- beat Marpai, Inc.'s return on equity of --.

Aveanna Healthcare Holdings, Inc. has a consensus price target of $11.00, signalling upside risk potential of 48.05%. On the other hand Marpai, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Aveanna Healthcare Holdings, Inc. has higher upside potential than Marpai, Inc., analysts believe Aveanna Healthcare Holdings, Inc. is more attractive than Marpai, Inc..

Aveanna Healthcare Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Marpai, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Aveanna Healthcare Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Marpai, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aveanna Healthcare Holdings, Inc. pays -- of its earnings as a dividend. Marpai, Inc. pays out -- of its earnings as a dividend.

Aveanna Healthcare Holdings, Inc. quarterly revenues are $621.9M, which are larger than Marpai, Inc. quarterly revenues of $4M. Aveanna Healthcare Holdings, Inc.'s net income of $14.1M is higher than Marpai, Inc.'s net income of -$3.5M. Notably, Aveanna Healthcare Holdings, Inc.'s price-to-earnings ratio is 20.64x while Marpai, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aveanna Healthcare Holdings, Inc. is 0.68x versus 0.35x for Marpai, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Pacific Health Care Organization, Inc. has a net margin of 2.26% compared to Aveanna Healthcare Holdings, Inc.'s net margin of 14.05%. Aveanna Healthcare Holdings, Inc.'s return on equity of -- beat Pacific Health Care Organization, Inc.'s return on equity of 11.97%.

Aveanna Healthcare Holdings, Inc. has a consensus price target of $11.00, signalling upside risk potential of 48.05%. On the other hand Pacific Health Care Organization, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Aveanna Healthcare Holdings, Inc. has higher upside potential than Pacific Health Care Organization, Inc., analysts believe Aveanna Healthcare Holdings, Inc. is more attractive than Pacific Health Care Organization, Inc..

Aveanna Healthcare Holdings, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pacific Health Care Organization, Inc. has a beta of 0.097, suggesting its less volatile than the S&P 500 by 90.301%.

Aveanna Healthcare Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pacific Health Care Organization, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.10 per share. Aveanna Healthcare Holdings, Inc. pays -- of its earnings as a dividend. Pacific Health Care Organization, Inc. pays out -- of its earnings as a dividend.

Aveanna Healthcare Holdings, Inc. quarterly revenues are $621.9M, which are larger than Pacific Health Care Organization, Inc. quarterly revenues of $1.6M. Aveanna Healthcare Holdings, Inc.'s net income of $14.1M is higher than Pacific Health Care Organization, Inc.'s net income of $223K. Notably, Aveanna Healthcare Holdings, Inc.'s price-to-earnings ratio is 20.64x while Pacific Health Care Organization, Inc.'s PE ratio is 11.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aveanna Healthcare Holdings, Inc. is 0.68x versus 2.40x for Pacific Health Care Organization, Inc.. Usually stocks with elevated PS ratios are considered overvalued.